These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


824 related items for PubMed ID: 23476073

  • 1. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome.
    Moghetti P, Tosi F, Bonin C, Di Sarra D, Fiers T, Kaufman JM, Giagulli VA, Signori C, Zambotti F, Dall'Alda M, Spiazzi G, Zanolin ME, Bonora E.
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E628-37. PubMed ID: 23476073
    [Abstract] [Full Text] [Related]

  • 2. The association between circulating irisin levels and different phenotypes of polycystic ovary syndrome.
    Zhang L, Fang X, Li L, Liu R, Zhang C, Liu H, Tan M, Yang G.
    J Endocrinol Invest; 2018 Dec; 41(12):1401-1407. PubMed ID: 29785700
    [Abstract] [Full Text] [Related]

  • 3. Metabolic syndrome and metabolic risk profile according to polycystic ovary syndrome phenotype.
    Bil E, Dilbaz B, Cirik DA, Ozelci R, Ozkaya E, Dilbaz S.
    J Obstet Gynaecol Res; 2016 Jul; 42(7):837-43. PubMed ID: 27071345
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in the Croatian population.
    Baldani DP, Skrgatić L, Simunić V, Zlopasa G, Canić T, Trgovcić I.
    Coll Antropol; 2013 Jun; 37(2):477-82. PubMed ID: 23940993
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.
    Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H.
    Hum Reprod; 2012 Oct; 27(10):3067-73. PubMed ID: 22777527
    [Abstract] [Full Text] [Related]

  • 10. Association between circulating zinc-α2-glycoprotein levels and the different phenotypes of polycystic ovary syndrome.
    Tang C, Li X, Tang S, Wang Y, Tan X.
    Endocr J; 2020 Mar 28; 67(3):249-255. PubMed ID: 31748429
    [Abstract] [Full Text] [Related]

  • 11. Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study.
    Hosseinpanah F, Barzin M, Keihani S, Ramezani Tehrani F, Azizi F.
    Clin Endocrinol (Oxf); 2014 Jul 28; 81(1):93-9. PubMed ID: 24428207
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian population.
    Pehlivanov B, Orbetzova M.
    Gynecol Endocrinol; 2007 Oct 28; 23(10):604-9. PubMed ID: 17852429
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Higher metabolic risk with National Institutes of Health versus Rotterdam diagnostic criteria for polycystic ovarian syndrome in Turkish women.
    Anaforoglu I, Algun E, Incecayir O, Ersoy K.
    Metab Syndr Relat Disord; 2011 Oct 28; 9(5):375-80. PubMed ID: 21657888
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 42.